GraniteShares Advisors LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1839545
NEW YORK, NY
Position in ALNY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$487,668
-$93,008 QoQ
Shares Held
1,620
-7.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#485
of 784 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GraniteShares Advisors LLC holds $2,939,290 across 5 Biotechnology names. ALNY ranks #3 (16.6% of the industry book) .
All Filings in ALNY
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $487,668 | 1,620 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $580,676 | 1,755 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $710,202 | 1,786 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $747,384 | 1,639 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $619,244 | 1,899 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $569,742 | 2,110 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $532,977 | 2,265 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $747,806 | 2,719 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $940,410 | 3,870 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $474,802 | 3,177 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $534,033 | 2,790 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $512,350 | 2,893 | Shares | Sole | 2023-10-31 | |
| 2021-12-31 | $100,900 | 595 | Shares | Sole | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||